Ellis Gary Lee 4

What Happened

• Gary Ellis, a director of Inspire Medical Systems, was granted 3,562 restricted stock units (RSUs) on April 30, 2026. The award was reported as an "A" (award/grant) transaction with an acquisition price of $0.00, meaning no cash was paid at grant. RSUs are a form of equity compensation and are not the same as an open-market purchase or sale.

Key Details

• Transaction date: 2026-04-30; filing date: 2026-05-04 (Form 4) — filed within the required reporting window.
• Shares/units granted: 3,562 RSUs; acquisition price shown: $0.00.
• Shares owned after transaction: not specified in the provided filing details.
• Footnote: Each RSU represents a contingent right to one share; vesting occurs upon the earlier of (a) the first anniversary of the grant or (b) immediately prior to a Change of Control, in each case subject to continued service.
• No 10b5-1 plan, tax-withholding sale, or cashless exercise was reported.

Context

• RSUs convey the right to receive shares in the future if vesting conditions are met; their eventual value depends on Inspire’s stock price at vesting. Such equity awards to directors are common as compensation and do not, by themselves, signal an immediate buy or sell of stock.